Antimicrobial Lipids of the Skin and Tear Film

Lipids and Essential Oils as Antimicrobial Agents

Volumn , Issue , 2010, Pages 99-121

  Bratt, Carol L ^a   Wertz, Phil ^a   Drake, David ^a   Dawson, Deborah V ^a   Brogden, Kim A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antimicrobial lipids of skin and tear film; Bacterial skin infections in normal individuals immunocompromised individuals and travelers, in specific occupations; Cutaneous innate immune mechanisms; Gram negative bacilli, as transient organisms flourishing, Gram positive flora suppressed by antibiotics; Gram positive cocci, Staphylococcus spp. and Streptococcus spp. contaminating cuts, burns, puncture wounds and abrasions; High antimicrobial activity of lipids applications in personal hygiene as deodorants; Innate immune mechanisms in skin extensive cutaneous microbial burden; Skin, durable and protective body surface covering physical barrier protecting underlying tissues against excessive temperature changes; Treponema pallidum ssp. and syphilis transmission, direct contact with active lesions; Types and locations of lipids of skin and tear film

Indexed keywords

EID: 84886135120     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470976623.ch5     Document Type: Chapter

References (130)

1. Proksch, E., Brandner, J.M. and Jensen, J.M. (2008) The skin: an indispensable barrier. Exp. Dermatol., 17, 1063-1072.
2. Lee, S.H., Jeong, S.K. and Ahn, S.K. (2006) An update of the defensive barrier function of skin. Yonsei Med. J., 47, 293-306.
3. Cameron, D.J., Tong, Z., Yang, Z. et al. (2007) Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int. J. Biol. Sci., 3, 111-119.
4. Schmid-Wendtner, M.H. and Korting, H.C. (2006) The pH of the skin surface and its impact on the barrier function. Skin Pharmacol. Physiol., 19, 296-302.
5. Levin, J. and Maibach, H. (2008) Human skin buffering capacity: an overview. Skin Res. Technol., 14, 121-126.
6. Elias, P.M. (2007) The skin barrier as an innate immune element. Semin. Immunopathol., 29, 3-14.
7. Jungersted, J.M., Hellgren, L.I., Jemec, G.B. and Agner, T. (2008) Lipids and skin barrier function: a clinical perspective. Contact Dermatitis, 58, 255-262.
8. Smith, K.R. and Thiboutot, D.M. (2008) Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe? J. Lipid Res., 49, 271-281.
9. Zouboulis, C.C., Baron, J.M., Bohm, M. et al. (2008) Frontiers in sebaceous gland biology and pathology. Exp. Dermatol., 17, 542-551.
10. Zouboulis, C.C. (2004) Acne and sebaceous gland function. Clin. Dermatol., 22, 360-366.
11. Robinson, P.G. (1982) Common names and abbreviated formulae for fatty acids. J. Lipid Res., 23, 1251-1253.
12. Noble,W.C. (ed.) (1992) The skin microflora and microbial skin disease, Cambridge University Press, Cambridge, UK.
13. Cogen, A.L., Nizet, V. and Gallo, R.L. (2008) Skin microbiota: a source of disease or defence? Brit. J. Dermatol., 158, 442-455.
14. Tannock, G.W. (1995) Normal Microflora: An Introduction to Microbes Inhabiting the Human Body, Chapman & Hall, London, UK.
15. Tannock, G.W. (ed.) (1999) Medical Importance of the Normal Microflora, Kluwer Academic Publishers, London, UK.
16. Fredricks, D.N. (2001) Microbial ecology of human skin in health and disease. J. Investig. Dermatol. Symp. Proc., 6, 167-169.
17. Hochedez, P. and Caumes, E. (2008) Common skin infections in travelers. J. Travel Med., 15, 252-262.
18. Bernard, P. (2008) Management of common bacterial infections of the skin. Curr. Opin. Infect. Dis., 21, 122-128.
19. Harries, M.J. and Lear, J.T. (2004) Occupational skin infections. Occup. Med. (Lond), 54, 441-449.
20. Bayston, R. andHiggins, J. (1986) Biochemical and cultural characteristics of 'JK'coryneforms. J. Clin. Pathol., 39, 654-660.
21. Blaise, G., Nikkels, A.F., Hermanns-Le, T. et al. (2008) Corynebacterium-associated skin infections. Int. J. Dermatol., 47, 884-890.
22. Coenye, T., Honraet, K., Rossel, B. and Nelis, H.J. (2008) Biofilms in skin infections: Propionibacterium acnes and acne vulgaris. Infect. Disord. Drug Targets, 8, 156-159.
23. Noble, W.C. and Savin, J.A. (1971) 'Gram-negative'infections of the skin. Brit. J. Dermatol., 85, 286-289.
24. Sebeny, P.J., Riddle, M.S. and Petersen, K. (2008) Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin. Infect. Dis., 47, 444-449.
25. Bhambri, S., Bhambri, A. and Del Rosso, J.Q. (2009) Atypical mycobacterial cutaneous infections. Dermatol. Clin., 27, 63-73.
26. Connolly, S.E. and Benach, J.L. (2005) The versatile roles of antibodies in Borrelia infections. Nat. Rev. Microbiol., 3, 411-420.
27. Hull, M.W. and Chow, A.W. (2007) Indigenous microflora and innate immunity of the head and neck. Infect. Dis. Clin. North Am., 21, 265-282.
28. Radek, K. and Gallo, R. (2007) Antimicrobial peptides: natural effectors of the innate immune system. Semin. Immunopathol., 29, 27-43.
29. Elias, P.M. (2005) Stratum corneum defensive functions: an integrated view. J. Invest.Dermatol., 125, 183-200.
30. Schauber, J. andGallo,R.L. (2008) Antimicrobial peptides and the skin immune defense system. J. Allergy Clin. Immunol., 122, 261-266.
31. Brogden, K.A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol., 3, 238-250.
32. Brown, K.L. and Hancock, R.E. (2006) Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol., 18, 24-30.
33. Ganz, T. (2004) Antimicrobial polypeptides. J. Leukoc. Biol., 75, 34-38.
34. Lehrer, R.I. (2004) Primate defensins. Nat. Rev. Microbiol., 2, 727-738.
35. Yamasaki, K. and Gallo, R.L. (2008) Antimicrobial peptides in human skin disease. Eur. J. Dermatol., 18, 11-21.
36. Braff, M.H. and Gallo, R.L. (2006) Antimicrobial peptides: an essential component of the skin defensive barrier. Curr. Top. Microbiol. Immunol., 306, 91-110.
37. Braff, M.H., Bardan, A., Nizet, V. and Gallo, R.L. (2005) Cutaneous defense mechanisms by antimicrobial peptides. J. Invest. Dermatol., 125, 9-13.
38. Niyonsaba, F. and Ogawa, H. (2005) Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. J. Dermatol. Sci., 40, 157-168.
39. Stoeckelhuber, M., Matthias, C., Andratschke, M. et al. (2006) Human ceruminous gland: ultrastructure and histochemical analysis of antimicrobial and cytoskeletal components. Anat. Rec. A. Discov. Mol. Cell Evol. Biol., 288, 877-884.
40. Buchau, A.S., Hassan, M., Kukova, G. et al. (2007) S100A15, an antimicrobial protein of the skin: regulation by E. coli through Toll-like receptor. J. Invest. Dermatol., 127, 2596-2604.
41. Lee, D.Y., Huang, C.M., Nakatsuji, T. et al. (2009) Histone H4 Is a major component of the antimicrobial action of human sebocytes. J. Invest. Dermatol., 129, 2489-2496.
42. Senyurek, I., Paulmann, M., Sinnberg, T. et al. (2009) Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus. Antimicrob. Agents Chemother., 53, 2499-2509.
43. Chen, X., Niyonsaba, F., Ushio, H. et al. (2005) Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci., 40, 123-132.
44. Ong, P.Y., Ohtake, T., Brandt, C. et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med., 347, 1151-1160.
45. Yamasaki, K., Di Nardo, A., Bardan, A. et al. (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med., 13, 975-980.
46. Hata, T.R. and Gallo, R.L. (2008) Antimicrobial peptides, skin infections, and atopic dermatitis. Semin. Cutan. Med. Surg., 27, 144-150.
47. Yamasaki, K. and Gallo, R.L. (2009) The molecular pathology of rosacea. J. Dermatol. Sci., 55, 77-81.
48. Dorschner, R.A., Pestonjamasp, V.K., Tamakuwala, S. et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol., 117, 91-97.
49. Drake, D.R., Brogden, K.A., Dawson, D.V. and Wertz, P.W. (2008) Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J. Lipid Res., 49, 4-11.
50. Thormar, H. and Hilmarsson, H. (2007) The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem. Phys. Lipids, 150, 1-11.
51. Freinkel, R.K. and Traczyk, T.N. (1985) Lipid composition and acid hydrolase content of lamellar granules of fetal rat epidermis. J. Invest. Dermatol., 85, 295-298.
52. Gray, G.M. and Yardley, H.J. (1975) Different populations of pig epidermal cells: isolation and lipid composition. J. Lipid Res., 16, 441-447.
53. Landmann, L. (1988) The epidermal permeability barrier. Anat Embryol (Berl), 178, 1-13.
54. Madison, K.C., Sando, G.N., Howard, E.J. et al. (1998) Lamellar granule biogenesis: a role for ceramide glucosyltransferase, lysosomal enzyme transport, and the Golgi. J. Investig. Dermatol. Symp. Proc., 3, 80-86.
55. Squier, C.A., Wertz, P.W. and Cox, P. (1991) Thin-layer chromatographic analyses of lipids in different layers of porcine epidermis and oral epithelium. Arch. Oral Biol., 36, 647-653.
56. Wertz, P.W., Downing, D.T., Freinkel, R.K. and Traczyk, T.N. (1984) Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidermis. J. Invest. Dermatol., 83, 193-195.
57. Wertz, P.W. and Downing, D.T. (1990) Ceramidase activity in porcine epidermis. FEBS Lett., 268, 110-112.
58. Yada, Y., Higuchi, K. and Imokawa, G. (1995) Purification and biochemical characterization of membrane-bound epidermal ceramidases from guinea pig skin. J. Biol. Chem., 270, 12677-12684.
59. Law, S., Wertz, P.W., Swartzendruber, D.C. and Squier, C.A. (1995) Regional variation in content, composition and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy. Arch. Oral Biol., 40, 1085-1091.
60. Ponec, M., Weerheim, A., Lankhorst, P. and Wertz, P. (2003) New acylceramide in native and reconstructed epidermis. J. Invest. Dermatol., 120, 581-588.
61. Wertz, P.W. and Downing, D.T. (1987) Covalently bound omega-hydroxyacylsphingosine in the stratum corneum. Biochim. Biophys. Acta, 917, 108-111.
62. Wertz, P.W. and Downing, D.T. (1989) Free sphingosines in porcine epidermis. Biochim. Biophys. Acta, 1002, 213-217.
63. Swartzendruber, D.C.,Wertz, P.W., Madison, K.C. and Downing, D.T. (1987) Evidence that the corneocyte has a chemically bound lipid envelope. J. Invest. Dermatol., 88, 709-713.
64. Weitkamp, A.W., Smiljanic, A.M. and Rothman, S. (1947) The free fatty acids of human hair fat. J. Am. Chem. Soc., 69, 1936-1939.
65. Ohashi, Y., Dogru, M. and Tsubota, K. (2006) Laboratory findings in tear fluid analysis. Clin. Chim. Acta, 369, 17-28.
66. Davidson, H.J. and Kuonen, V.J. (2004) The tear film and ocular mucins. Vet. Ophthalmol., 7, 71-77.
67. Tiffany, J.M. (2008) The normal tear film. Dev. Ophthalmol., 41, 1-20.
68. Bron, A.J., Tiffany, J.M., Gouveia, S.M. et al. (2004) Functional aspects of the tear film lipid layer. Exp. Eye Res., 78, 347-360.
69. Butovich, I.A. (2008) On the lipid composition of human meibum and tears: comparative analysis of nonpolar lipids. Invest. Ophthalmol. Vis. Sci., 49, 3779-3789.
70. Huang, L.C., Jean, D., Proske, R.J. et al. (2007) Ocular surface expression and in vitro activity of antimicrobial peptides. Curr. Eye Res., 32, 595-609.
71. Nichols, K.K., Ham, B.M., Nichols, J.J. et al. (2007) Identification of fatty acids and fatty acid amides in human meibomian gland secretions. Invest. Ophthalmol. Vis. Sci., 48, 34-39.
72. Shine,W.E. andMcCulley, J.P. (2003) Polar lipids in human meibomian gland secretions. Curr. Eye Res., 26, 89-94.
73. Nicolaides, N., Santos, E.C., Papadakis, K. et al. (1984) The occurrence of long chain alpha, omega-diols in the lipids of steer and human meibomian glands. Lipids, 19, 990-993.
74. Nicolaides, N., Kaitaranta, J.K., Rawdah, T.N. et al. (1981) Meibomian gland studies: comparison of steer and human lipids. Invest. Ophthalmol. Vis. Sci., 20, 522-536.
75. Butovich, I.A., Uchiyama, E. and McCulley, J.P. (2007) Lipids of human meibum: massspectrometric analysis and structural elucidation. J. Lipid Res., 48, 2220-2235.
76. Butovich, I.A. (2009) Cholesteryl esters as a depot for very long chain fatty acids in human meibum. J. Lipid Res., 50, 501-513.
77. Li, W., Sandhoff, R., Kono, M. et al. (2007) Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int. J. Biol. Sci., 3, 120-128.
78. Bayliss, M. (1936) Effect of the chemical constitution of soaps upon their germicidal properties. J. Bacteriol., 31, 489-504.
79. Kabara, J.J. and Vrable, R. (1977) Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides. Lipids, 12, 753-759.
80. Bergsson, G., Arnfinnsson, J., Steingrimsson, O. and Thormar, H. (2001) In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob. Agents Chemother., 45, 3209-3212.
81. Burtenshaw, J.M. (1942) The mechanisms of self disinfection of the human skin and its appendages. J. Hyg. (Lond.), 42, 184-209.
82. Bibel, D.J., Aly, R., Shah, S. and Shinefield, H.R. (1993) Sphingosines: antimicrobial barriers of the skin. Acta Derm. Venereol., 73, 407-411.
83. Bibel, D.J., Aly, R. and Shinefield, H.R. (1992) Antimicrobial activity of sphingosines. J. Invest. Dermatol., 98, 269-273.
84. Bibel, D.J.,Aly,R. and Shinefield, H.R. (1995)Topical sphingolipids in antisepsis and antifungal therapy. Clin. Exp. Dermatol., 20, 395-400.
85. Payne, C.D., Ray, T.L. and Downing, D.T. (1996) Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro. J. Invest. Dermatol., 106, 549-552.
86. Brogden, K.A. (2009) Cytopathology of pathogenic prokaryotes, in Ultrastructural Pathology: The Cellular Basis of Disease, 2nd edn (ed. N. Cheville), Blackwell Publishers, Ames, IA, USA, pp. 425-524.
87. Verkley, A.J., Ververgaert, P.H., Prins, R.A. and van Golde, L.M. (1975) Lipid-phase transitions of the strictly anaerobic bacteria Veillonella parvula and Anaerovibrio lipolytica. J. Bacteriol., 124, 1522-1528.
88. Beveridge, T.J. (1999) Structures of gram-negative cell walls and their derived membrane vesicles. J. Bacteriol., 181, 4725-4733.
89. Alvarez, H.M. and Steinbuchel, A. (2002) Triacylglycerols in prokaryotic microorganisms. Appl. Microbiol. Biotechnol., 60, 367-376. 9
90. Kalscheuer, R., Stoveken, T., Malkus, U. et al. (2007) Analysis of storage lipid accumulation in Alcanivorax borkumensis: evidence for alternative triacylglycerol biosynthesis routes in bacteria. J. Bacteriol., 189, 918-928. 9
91. Imokawa, G. (2001) Lipid abnormalities in atopic dermatitis. J. Am. Acad. Dermato.l, 45, S29-32. 9
92. Macheleidt, O., Kaiser, H.W. and Sandhoff, K. (2002) Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J. Invest. Dermatol., 119, 166-173. 9
93. Arikawa, J., Ishibashi, M., Kawashima, M. et al. (2002) Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J. Invest. Dermatol., 119, 433-439. 9
94. Takigawa, H., Nakagawa, H., Kuzukawa,M. et al. (2005) Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus. Dermatology, 211, 240-248. 9
95. Georgel, P., Crozat, K., Lauth, X. et al. (2005) A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect. Immun., 73, 4512-4521. 9
96. Ruzin, A. and Novick, R.P. (2000) Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J. Bacteriol., 182, 2668-2671. 9
97. Ruzin, A. and Novick, R.P. (1998) Glycerol monolaurate inhibits induction of vancomycin resistance in Enterococcus faecalis. J. Bacteriol., 180, 182-185. 9
98. Projan, S.J., Brown-Skrobot, S., Schlievert, P.M. et al. (1994) Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J. Bacteriol., 176, 4204-4209. 9
99. Nakatsuji, T., Kao, M.C., Fang, J.Y. et al. (2009) Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J. Invest. Dermatol., 129, 2480-2488.
100. Nojima, H., Ohba, Y. and Kita, Y. (2007) Oleamide derivatives are prototypical anti-metastasis drugs that act by inhibiting Connexin. Curr. Drug Saf., 2, 204-211.
101. Bergsson, G., Arnfinnsson, J., Steingrimsson, O. and Thormar, H. (2001) Killing of Grampositive cocci by fatty acids and monoglycerides. APMIS, 109, 670-678.
102. Robertson, E., Brogden, K., Wertz, P. et al. (2005) Antimicrobial activity of human skin lipids, Abstr. 345.3rd General Session IADR meeting, Baltimore, MD, USA.
103. Robertson, E., Burnell, K., Qian, F. et al. (2006) Synergistic activity of human skin lipids and LL-37, Abstr. 211. 4th General Session IADR meeting, Orlando, FL, USA.
104. Klee, S.K., Farwick, M. and Lersch, P. (2007) The effect of sphingolipids as a new therapeutic option for acne treatment. Basic Clin. Dermatol, 40, 155-156.
105. Pavicic, T., Wollenweber, U., Farwick, M. and Korting, H.C. (2007) Anti-microbial and-inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int. J. Cosmet. Sci., 29, 181-190.
106. Labows, J., Reilly, J., Leyden, J. and Preti, G. (1999) Axillary odor determination, formulation, and control, in Antiperspirants and Deodorants, 2nd edn (ed. K. Laden), Marcel Dekker, New York, NY, USA, pp. 59-82.
107. Granato, P.A. (2003) Pathogenic and indigenous microorganisms of humans, in Manual of Clinical Microbiology. 1, (eds P.R. Murray, E.J. Baron, J.H. Jorgensen et al.), ASM Press, Washington, DC, USA, pp. 44-54.
108. Oncul, O., Ozsoy, M.F., Gul, H.C. et al. (2002) Cutaneous anthrax in Turkey: a review of 32 cases. Scand. J. Infect. Dis., 34, 413-416.
109. Janda, W.M., Tipirneni, P. and Novak, R.M. (2003) Brevibacterium casei bacteremia and line sepsis in a patient with AIDS. J. Infect., 46, 61-64.
110. Hojyo-Tomoka, M.T., Marples, R.R. and Kligman, A.M. (1973) Pseudomonas infection in superhydrated skin. Arch. Dermatol., 107, 723-727.
111. Niyonsaba, F., Ushio, H., Nagaoka, I. et al. (2005) The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J. Immunol., 175, 1776-1784.
112. Niyonsaba, F., Ushio, H., Nakano, N. et al. (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol., 127, 594-604.
113. Niyonsaba, F., Iwabuchi, K., Matsuda, H. et al. (2002) Epithelial cell-derived human betadefensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int. Immunol., 14, 421-426.
114. Niyonsaba, F., Someya,A., Hirata,M. et al. (2001) Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol., 31, 1066-1075.
115. Chen, X., Niyonsaba, F., Ushio, H. et al. (2007) Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur. J. Immunol., 37, 434-444.
116. Zheng, Y., Niyonsaba, F., Ushio, H. et al. (2007) Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Brit. J. Dermatol., 157, 1124-1131.
117. Niyonsaba, F., Iwabuchi, K., Someya, A. et al. (2002) A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology, 106, 20-26.
118. Niyonsaba, F., Suzuki, A., Ushio, H. et al. (2009) The human antimicrobial peptide dermcidin activates normal human keratinocytes. Brit. J. Dermatol., 160, 243-249.
119. Allaker, R.P. and Kapas, S. (2003) Adrenomedullin and mucosal defence: interaction between host and microorganism. Regul. Pept., 112, 147-152.
120. Niyonsaba, F., Hattori, F., Maeyama, K. et al. (2008) Induction of a microbicidal protein psoriasin (S100A7), and its stimulatory effects on normal human keratinocytes. J. Dermatol. Sci., 52, 216-219.
121. Zheng, Y., Niyonsaba, F., Ushio, H. et al. (2008) Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology, 124, 357-367.
122. Grayson, S., Johnson-Winegar, A.G., Wintroub, B.U. et al. (1985) Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J. Invest. Dermatol., 85, 289-294.
123. Stewart, M.E. and Downing, D.T. (1995) Free sphingosines of human skin include 6-hydroxysphingosine and unusually long-chain dihydrosphingosines. J. Invest. Dermatol., 105, 613-618.
124. Saito, H., Tomioka, H. and Yoneyama, T. (1984) Growth of group IV mycobacteria on medium containing various saturated and unsaturated fatty acids. Antimicrob. Agents Chemother., 26, 164-169.
125. Kitahara, T., Koyama, N., Matsuda, J. et al. (2004) Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull., 27, 1321-1326.
126. Shirane, J., Nakayama, T., Nagakubo, D. et al. (2004) Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis. Curr. Eye Res., 28, 297-306.
127. McDermott, A.M., Redfern, R.L. and Zhang, B. (2001) Human beta-defensin 2 is up-regulated during re-epithelialization of the cornea. Curr. Eye Res., 22, 64-67.
128. McDermott, A.M., Redfern, R.L., Zhang, B. et al. (2003) Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci., 44, 1859-1865.
129. Gordon, Y.J., Huang, L.C., Romanowski, E.G. et al. (2005) Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr. Eye Res., 30, 385-394.
130. Spandau, U.H., Toksoy, A., Verhaart, S. et al. (2003) High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch. Ophthalmol., 121, 825-831.